Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 9/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.49 |
| ▸ | AGPAT2 | O15120 | 4/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | SCN4A | P35499 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.43 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15757374 | 1.00 | NUDT1 (1.00) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL17407834 | 0.90 | NUDT1 (0.82) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15757710 | 0.88 | NUDT1 (0.78) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15756934 | 0.87 | NUDT1 (0.77) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15757415 | 0.87 | NUDT1 (0.77) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15757546 | 0.86 | NUDT1 (0.75) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15757202 | 0.86 | NUDT1 (0.75) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL17315298 | 0.85 | NUDT1 (0.73) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15756926 | 0.85 | NUDT1 (0.73) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 | |
| SCHEMBL15757292 | 0.85 | NUDT1 (0.73) | NUDT1PTPN1HSP90AA1HSP90AB1AGPAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116041712-B | Protoporphyrin modified cellulose grafted polylactic acid, tumor targeting stereocomplex drug-loaded nano micelle thereof, and preparation method and application thereof | 四川大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117883409-A | Medicine-carrying calcium-based nano generator wrapped by plant-derived exosomes, preparation method and anti-tumor application thereof | 中山大学·深圳 | 2024-04-16 | — | — | CN | claimed |
| CN-116041712-A | Protoporphyrin modified cellulose grafted polylactic acid, tumor targeting stereocomplex drug-loaded nano micelle thereof, and preparation method and application thereof | 四川大学 | 2023-05-02 | — | — | CN | claimed |
| CN-115554401-A | Preparation of unsupported multifunctional nanoparticles based on ruthenium complex and anti-tumor application of unsupported multifunctional nanoparticles | 重庆医科大学 | 2023-01-03 | — | — | CN | claimed |
| CN-119905139-B | Application of small molecular substance TH287 in preventing and treating rice blast | 南京农业大学 | 2025-11-28 | — | — | CN | disclosed |
| CN-119905139-B | Application of small molecular substance TH287 in preventing and treating rice blast | 南京农业大学 | 2025-11-28 | — | — | CN | disclosed |
| US-20250282803-A1 | DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ROME THERAPEUTICS, INC. | 2025-09-11 | — | — | US | disclosed |
| US-20250268925-A1 | METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED ADENINYL-PROPYLOXY PHOSPHONIC ACID OR RELATED COMPOUND | ROME THERAPEUTICS, INC. | 2025-08-28 | — | — | US | disclosed |
| US-20250186467-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING STAMPIDINE OR A RELATED COMPOUND | ROME THERAPEUTICS, INC. | 2025-06-12 | — | — | US | disclosed |
| US-20250186475-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING ISLATRAVIR OR A RELATED COMPOUND | ROME THERAPEUTICS, INC. | 2025-06-12 | — | — | US | disclosed |
| US-20250170158-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING CENSAVUDINE OR A RELATED COMPOUND | ROME THERAPEUTICS, INC. | 2025-05-29 | — | — | US | disclosed |
| US-20250145654-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS, INC. | 2025-05-08 | — | — | US | disclosed |
| CN-110025627-B | Medicine for preventing and treating tumor and its use | 蔡剑平 | 2022-06-17 | — | — | CN | disclosed |
| US-20220175714-A1 | USE OF RIVASTIGMINE IN PREPARATION OF ANTI-RADIATION MEDICAMENT | SOOCHOW UNIVERSITY (CN) | 2022-06-09 | — | — | US | disclosed |
| CN-108191774-B | Heterocyclic compound, preparation method and application thereof | 中国药科大学 | 2022-05-24 | — | — | CN | disclosed |
| EP-3307738-B1 | ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE | UNIV MICHIGAN REGENTS (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022051567-A1 | SUBSTITUTED PYRIDO[2,3-B]PYRAZINONES AND REUATED COMPOUNDS AND THEIR USE IN TREATING MEDICAU CONDITIONS | Ikena Oncology, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051569-A1 | SUBSTITUTED 3-PIPERIDINYL-PYRROLO[2,3-B]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Ikena Oncology, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051565-A1 | SUBSTITUTED 4-PIPERIDINYL-QUINAZOLINES, 4-PIPERIDINYL-PYRIMIDINE-2-AMINES, AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Ikena Oncology, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051568-A1 | SUBSTITUTED 4-PIPERIDINYL-PYRROLO[2,3-B]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Ikena Oncology, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170158-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING CENSAVUDINE OR A RELATED COMPOUND | TRDMT1, TPMT, EHMT1 | NUDT1 45/4885PTPN1 2463/4885HSP90AA1 2207/4885 |
| US-20250268925-A1 | METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED ADENINYL-PROPYLOXY PHOSPHONIC ACID OR RELATED COMPOUND | POLI, POLRMT, POLN | NUDT1 65/4885PTPN1 2866/4885HSP90AA1 1099/4885 |
| US-20250282803-A1 | DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | DTYMK, DCK, POLK | NUDT1 200/4885PTPN1 2952/4885HSP90AA1 2134/4885 |
| US-20250186475-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING ISLATRAVIR OR A RELATED COMPOUND | POLRMT, RNASE1, REV1 | NUDT1 225/4885PTPN1 3624/4885HSP90AA1 1433/4885 |
| US-20250186467-A1 | METHODS OF TREATING MEDICAL CONDITIONS USING STAMPIDINE OR A RELATED COMPOUND | EHMT1, TRDMT1, POLRMT | NUDT1 980/4885PTPN1 1471/4885HSP90AA1 444/4885 |
| US-20250145654-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | EHMT1, POLRMT, RNASE1 | NUDT1 325/4885PTPN1 2063/4885HSP90AA1 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.